- Home
- Publications
- Publication Search
- Publication Details
Title
B Cell Aberrance in Lupus: the Ringleader and the Solution
Authors
Keywords
-
Journal
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-03
DOI
10.1007/s12016-020-08820-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antagonizing miR-7 suppresses B cell hyperresponsiveness and inhibits lupus development
- (2020) Min Wang et al. JOURNAL OF AUTOIMMUNITY
- Update on the cellular and molecular aspects of lupus nephritis
- (2020) Eleni Frangou et al. CLINICAL IMMUNOLOGY
- CALIBRATE: A Phase 2 Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis
- (2020) Yemil Atisha‐Fregoso et al. Arthritis & Rheumatology
- In vitro elimination of autoreactive B cells from rheumatoid arthritis patients by universal chimeric antigen receptor T cells
- (2020) Bo Zhang et al. ANNALS OF THE RHEUMATIC DISEASES
- Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
- (2020) Richard Furie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol
- (2019) Y K Onno Teng et al. BMJ Open
- Epigenetic regulation of B cell fate and function during an immune response
- (2019) Yan Zhang et al. IMMUNOLOGICAL REVIEWS
- CXCR4 and CXCR5 orchestrate dynamic germinal center reactions and may contribute to the pathogenesis of systemic lupus erythematosus
- (2019) Bing-xuan Wu et al. Cellular & Molecular Immunology
- Loss of epigenetic modifications on the inactive X chromosome and sex-biased gene expression profiles in B cells from NZB/W F1 mice with lupus-like disease
- (2019) Camille M. Syrett et al. JOURNAL OF AUTOIMMUNITY
- B cells in autoimmune and neurodegenerative central nervous system diseases
- (2019) Joseph J. Sabatino et al. NATURE REVIEWS NEUROSCIENCE
- An update on genetic susceptibility in lupus nephritis
- (2019) Kangkang Song et al. CLINICAL IMMUNOLOGY
- The pathogenesis of systemic lupus erythematosus: Harnessing big data to understand the molecular basis of lupus
- (2019) Michelle D. Catalina et al. JOURNAL OF AUTOIMMUNITY
- Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial
- (2019) Alexis Jones et al. BMJ Open
- A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea
- (2018) Fengchun Zhang et al. ANNALS OF THE RHEUMATIC DISEASES
- Self-Reactive B Cells in the Germinal Center Reaction
- (2018) Robert Brink et al. Annual Review of Immunology
- Epigenetic regulation in B-cell maturation and its dysregulation in autoimmunity
- (2018) Haijing Wu et al. Cellular & Molecular Immunology
- Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma
- (2018) Constantine S. Tam et al. NEW ENGLAND JOURNAL OF MEDICINE
- Kin discrimination allows plants to modify investment towards pollinator attraction
- (2018) Rubén Torices et al. Nature Communications
- Brief Report: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis
- (2018) Laurence E. Cheng et al. Arthritis & Rheumatology
- Long-Term Safety and Efficacy of Belimumab in Patients With Systemic Lupus Erythematosus
- (2018) Richard A. Furie et al. Arthritis & Rheumatology
- Bruton’s Tyrosine Kinase, a Component of B Cell Signaling Pathways, Has Multiple Roles in the Pathogenesis of Lupus
- (2018) Anne B. Satterthwaite Frontiers in Immunology
- Plasma Cell Differentiation Pathways in Systemic Lupus Erythematosus
- (2018) Susan Malkiel et al. Frontiers in Immunology
- Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial
- (2018) Joan T Merrill et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 655064, an Antagonistic Anti-CD40 Antibody, in Healthy Subjects: A Potential Novel Treatment for Autoimmune Diseases
- (2018) Christian Schwabe et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus
- (2018) Kei Sakata et al. Frontiers in Immunology
- Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond
- (2018) Jodi L. Karnell et al. ADVANCED DRUG DELIVERY REVIEWS
- B cell–derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity
- (2017) Tanvi Arkatkar et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Aiolos Overexpression in Systemic Lupus Erythematosus B Cell Subtypes and BAFF-Induced Memory B Cell Differentiation Are Reduced by CC-220 Modulation of Cereblon Activity
- (2017) Yumi Nakayama et al. JOURNAL OF IMMUNOLOGY
- Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples
- (2017) Venkat Reddy et al. RHEUMATOLOGY
- Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials
- (2017) Megan E. B. Clowse et al. Arthritis & Rheumatology
- Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study
- (2017) William Stohl et al. Arthritis & Rheumatology
- Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification
- (2016) Melissa E Munroe et al. ANNALS OF THE RHEUMATIC DISEASES
- Contribution and underlying mechanisms of CXCR4 overexpression in patients with systemic lupus erythematosus
- (2016) Li-dan Zhao et al. Cellular & Molecular Immunology
- The role of Bruton’s tyrosine kinase in autoimmunity and implications for therapy
- (2016) Leslie J. Crofford et al. Expert Review of Clinical Immunology
- Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies
- (2016) Rufei Lu et al. JOURNAL OF AUTOIMMUNITY
- B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6
- (2016) Shaun W. Jackson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Genome-wide association meta-analysis in Chinese and European individuals identifies ten new loci associated with systemic lupus erythematosus
- (2016) David L Morris et al. NATURE GENETICS
- High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry
- (2016) Celi Sun et al. NATURE GENETICS
- Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
- (2015) J T Merrill et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
- (2015) D A Isenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- The mechanistic impact of CD22 engagement with epratuzumab on B cell function: Implications for the treatment of systemic lupus erythematosus
- (2015) Thomas Dörner et al. AUTOIMMUNITY REVIEWS
- FAS Inactivation Releases Unconventional Germinal Center B Cells that Escape Antigen Control and Drive IgE and Autoantibody Production
- (2015) Danyal Butt et al. IMMUNITY
- Pathogenesis of Renal Disease in Systemic Lupus Erythematosus—The Role of Autoantibodies and Lymphocytes Subset Abnormalities
- (2015) Desmond Yap et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Role ofPTPN22Risk Variant in the Development of Autoimmunity: Finding Common Ground between Mouse and Human
- (2015) David J. Rawlings et al. JOURNAL OF IMMUNOLOGY
- Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus
- (2015) Christopher M Tipton et al. NATURE IMMUNOLOGY
- B cells biology in systemic lupus erythematosus—from bench to bedside
- (2015) LiDan Zhao et al. Science China-Life Sciences
- Treatment of systemic lupus erythematosus patients with the BAFF antagonist “peptibody” blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials
- (2015) William Stohl et al. ARTHRITIS RESEARCH & THERAPY
- A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study
- (2014) R A Furie et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)
- (2014) David Isenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- T/B-cell interactions are more transient in response to weak stimuli in SLE-prone mice
- (2014) Parisa Sinai et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Signaling Role of CD40 Ligand in Platelet Biology and in Platelet Component Transfusion
- (2014) Chaker Aloui et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Suppression of innate and adaptive B cell activation pathways by antibody coengagement of FcγRIIb and CD19
- (2014) Dániel Szili et al. mAbs
- Transcriptional and metabolic pre-B cell receptor-mediated checkpoints: Implications for autoimmune diseases
- (2014) Moncef Zouali MOLECULAR IMMUNOLOGY
- The BAFF/APRIL system in SLE pathogenesis
- (2014) Fabien B. Vincent et al. Nature Reviews Rheumatology
- Ofatumumab: a novel treatment for severe systemic lupus erythematosus
- (2014) C. C. Thornton et al. RHEUMATOLOGY
- Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus
- (2014) X.-n. Wu et al. Science Translational Medicine
- Impaired Suppressive Capacity of Activation-Induced Regulatory B Cells in Systemic Lupus Erythematosus
- (2014) Nele Gao et al. Arthritis & Rheumatology
- Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
- (2013) Marie B Condon et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study
- (2013) Daniel J Wallace et al. ANNALS OF THE RHEUMATIC DISEASES
- Suppression of Glomerulonephritis in Lupus-Prone NZB × NZW Mice by RN486, a Selective Inhibitor of Bruton's Tyrosine Kinase
- (2013) Paola Mina-Osorio et al. ARTHRITIS AND RHEUMATISM
- Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double-Blind, Phase III Study
- (2013) Eduardo F. Mysler et al. ARTHRITIS AND RHEUMATISM
- Genetic susceptibility to SLE: Recent progress from GWAS
- (2013) Yong Cui et al. JOURNAL OF AUTOIMMUNITY
- Selective Inhibition of BTK Prevents Murine Lupus and Antibody-Mediated Glomerulonephritis
- (2013) A. L. Rankin et al. JOURNAL OF IMMUNOLOGY
- TLR9 Promotes Tolerance by Restricting Survival of Anergic Anti-DNA B Cells, Yet Is Also Required for Their Activation
- (2013) K. M. Nickerson et al. JOURNAL OF IMMUNOLOGY
- Exacerbated Autoimmunity in the Absence of TLR9 in MRL.Faslpr Mice Depends on Ifnar1
- (2013) K. M. Nickerson et al. JOURNAL OF IMMUNOLOGY
- Role of Nucleic Acid-Sensing TLRs in Diverse Autoantibody Specificities and Anti-Nuclear Antibody-Producing B Cells
- (2013) Y. T. Koh et al. JOURNAL OF IMMUNOLOGY
- Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up
- (2013) Daniel J. Wallace et al. RHEUMATOLOGY
- MicroRNA-3148 Modulates Allelic Expression of Toll-Like Receptor 7 Variant Associated with Systemic Lupus Erythematosus
- (2013) Yun Deng et al. PLoS Genetics
- Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve-Month, Randomized, Double-Blind Study
- (2013) Richard Furie et al. Arthritis & Rheumatology
- The establishment of early B cell tolerance in humans: lessons from primary immunodeficiency diseases
- (2012) Eric Meffre Annals of the New York Academy of Sciences
- Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
- (2012) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
- (2012) George K Bertsias et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice
- (2012) L. P. Kil et al. BLOOD
- Follicular helper T cells in immunity and systemic autoimmunity
- (2012) Joseph E. Craft Nature Reviews Rheumatology
- Aberrant CD40-Induced NF-κB Activation in Human Lupus B Lymphocytes
- (2012) Wen Zhang et al. PLoS One
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
- (2012) Bevra H. Hahn et al. ARTHRITIS CARE & RESEARCH
- Modulating proximal cell signaling by targeting Btk ameliorates humoral autoimmunity and end-organ disease in murine lupus
- (2012) Jack Hutcheson et al. ARTHRITIS RESEARCH & THERAPY
- Genome-wide DNA methylation patterns in CD4+ T cells from patients with systemic lupus erythematosus
- (2011) Matlock Jeffries et al. Epigenetics
- The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans
- (2011) Laurence Menard et al. JOURNAL OF CLINICAL INVESTIGATION
- Enhanced Phosphoinositide 3-Kinase Activity Is a Frequent Event in Systemic Lupus Erythematosus That Confers Resistance to Activation-Induced T Cell Death
- (2011) A. Suarez-Fueyo et al. JOURNAL OF IMMUNOLOGY
- Altered B Cell Homeostasis Is Associated with Type I Diabetes and Carriers of the PTPN22 Allelic Variant
- (2011) T. Habib et al. JOURNAL OF IMMUNOLOGY
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- FcγRIIB, FcγRIIIB, and systemic lupus erythematosus
- (2010) Heather A. Niederer et al. Annals of the New York Academy of Sciences
- The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: Results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial
- (2010) J. T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression
- (2010) A. KITANI et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Off-label use of rituximab in systemic lupus erythematosus: a systematic review
- (2010) Eleanor Murray et al. CLINICAL RHEUMATOLOGY
- TLR1/2, TLR7, and TLR9 Signals Directly Activate Human Peripheral Blood Naive and Memory B Cell Subsets to Produce Cytokines, Chemokines, and Hematopoietic Growth Factors
- (2010) Sudhanshu Agrawal et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Anti-CD40L Immune Complexes Potently Activate Platelets In Vitro and Cause Thrombosis in FCGR2A Transgenic Mice
- (2010) L. Robles-Carrillo et al. JOURNAL OF IMMUNOLOGY
- TLR9 Regulates TLR7- and MyD88-Dependent Autoantibody Production and Disease in a Murine Model of Lupus
- (2010) Kevin M. Nickerson et al. JOURNAL OF IMMUNOLOGY
- Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus
- (2010) N. Shen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- B Cell Receptor Signaling: Picky About PI3Ks
- (2010) J. J. Limon et al. Science Signaling
- Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus
- (2010) Capucine Daridon et al. ARTHRITIS RESEARCH & THERAPY
- Refractory severe connective tissue disease thrombocytopenia: is rituximab treatment effective and safe?
- (2009) W J Zheng et al. ANNALS OF THE RHEUMATIC DISEASES
- A polymorphism withinIL21Rconfers risk for systemic lupus erythematosus
- (2009) Ryan Webb et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- PI3 Kinase Signals BCR-Dependent Mature B Cell Survival
- (2009) Lakshmi Srinivasan et al. CELL
- Suppression of Phosphatidylinositol 3,4,5-Trisphosphate Production Is a Key Determinant of B Cell Anergy
- (2009) Cecille D. Browne et al. IMMUNITY
- Molecular mechanism and function of CD40/CD40L engagement in the immune system
- (2009) Raul Elgueta et al. IMMUNOLOGICAL REVIEWS
- Toll-like receptors - sentries in the B-cell response
- (2009) Isabelle Bekeredjian-Ding et al. IMMUNOLOGY
- Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice
- (2009) Marie-Laure Santiago-Raber et al. JOURNAL OF AUTOIMMUNITY
- B Cells and Immunological Tolerance
- (2009) Nataly Manjarrez-Orduño et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Checkpoints in lymphocyte development and autoimmune disease
- (2009) Harald von Boehmer et al. NATURE IMMUNOLOGY
- CD19: a promising B cell target for rheumatoid arthritis
- (2009) Thomas F. Tedder Nature Reviews Rheumatology
- A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice
- (2009) J. A. Bubier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Abetimus sodium for renal flare in systemic lupus erythematosus: Results of a randomized, controlled phase III trial
- (2008) Mario H. Cardiel et al. ARTHRITIS AND RHEUMATISM
- APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells
- (2008) E. Belnoue et al. BLOOD
- Yaaautoimmune phenotypes are conferred by overexpression of TLR7
- (2008) Anna‐Marie Fairhurst et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Sites and Stages of Autoreactive B Cell Activation and Regulation
- (2008) Mark J. Shlomchik IMMUNITY
- Generation of T Follicular Helper Cells Is Mediated by Interleukin-21 but Independent of T Helper 1, 2, or 17 Cell Lineages
- (2008) Roza I. Nurieva et al. IMMUNITY
- Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells
- (2008) Kristina E. Halcomb et al. MOLECULAR IMMUNOLOGY
- Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci
- (2008) John B Harley et al. NATURE GENETICS
- Foxo1 directly regulates the transcription of recombination-activating genes during B cell development
- (2008) Rupesh H Amin et al. NATURE IMMUNOLOGY
- Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation
- (2008) Hart S Dengler et al. NATURE IMMUNOLOGY
- Systemic Lupus Erythematosus
- (2008) Anisur Rahman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus
- (2008) Richard Furie et al. ARTHRITIS RESEARCH & THERAPY
- Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse
- (2007) K Komura et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-21: Basic Biology and Implications for Cancer and Autoimmunity
- (2007) Rosanne Spolski et al. Annual Review of Immunology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now